https://clinicaltrials.gov/ct2/show/NCT03407482?type=Intr&cond=Lupus&phase=012345&lupd_s=02%2F01%2F2019&lupd_d=14
Condition : Lupus Erythematosus, Systemic
Intervention : Drug: GDC-0853
Sponsor : Genentech, Inc.
Recruiting
An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
NCT03407482
Tue, 23 Jan 2018 12:00:00 EST
